Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1983 1
1984 1
1987 1
1988 1
1989 3
1991 1
1992 2
1993 5
1994 4
1995 7
1996 5
1997 13
1998 12
1999 20
2000 27
2001 33
2002 41
2003 54
2004 62
2005 85
2006 91
2007 116
2008 112
2009 146
2010 186
2011 244
2012 293
2013 310
2014 349
2015 335
2016 309
2017 285
2018 248
2019 235
2020 272
2021 303
2022 288
2023 267
2024 222

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,301 results

Results by year

Filters applied: . Clear all
Page 1
Brain lipidomics: From functional landscape to clinical significance.
Yoon JH, Seo Y, Jo YS, Lee S, Cho E, Cazenave-Gassiot A, Shin YS, Moon MH, An HJ, Wenk MR, Suh PG. Yoon JH, et al. Sci Adv. 2022 Sep 16;8(37):eadc9317. doi: 10.1126/sciadv.adc9317. Epub 2022 Sep 16. Sci Adv. 2022. PMID: 36112688 Free PMC article. Review.
GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.
Lee YJ, Shin KJ, Jang HJ, Ryu JS, Lee CY, Yoon JH, Seo JK, Park S, Lee S, Je AR, Huh YH, Kong SY, Kwon T, Suh PG, Chae YC. Lee YJ, et al. Among authors: yoon jh. Dev Cell. 2023 Feb 27;58(4):320-334.e8. doi: 10.1016/j.devcel.2023.01.006. Epub 2023 Feb 16. Dev Cell. 2023. PMID: 36800996 Free article.
Response.
Lee H, Kim Y, Yoon JH, Choi H. Lee H, et al. Among authors: yoon jh. Chest. 2023 Mar;163(3):e148. doi: 10.1016/j.chest.2022.11.037. Chest. 2023. PMID: 36894273 No abstract available.
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.
Kim RD, Sarker D, Meyer T, Yau T, Macarulla T, Park JW, Choo SP, Hollebecque A, Sung MW, Lim HY, Mazzaferro V, Trojan J, Zhu AX, Yoon JH, Sharma S, Lin ZZ, Chan SL, Faivre S, Feun LG, Yen CJ, Dufour JF, Palmer DH, Llovet JM, Manoogian M, Tugnait M, Stransky N, Hagel M, Kohl NE, Lengauer C, Sherwin CA, Schmidt-Kittler O, Hoeflich KP, Shi H, Wolf BB, Kang YK. Kim RD, et al. Among authors: yoon jh. Cancer Discov. 2019 Dec;9(12):1696-1707. doi: 10.1158/2159-8290.CD-19-0555. Epub 2019 Oct 1. Cancer Discov. 2019. PMID: 31575541 Free article. Clinical Trial.
4,301 results